MetaCap

Who Owns Virax Biolabs Group Stock?

NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

1.89-0.10 (-5.03%)

Market open · Delayed 15 min · as of Oct 9, 1:13 PM ET

Ownership breakdown

Held by institutions
1.99%
Institutional holders
2
  • Institutions 2.0%
  • Insiders 1.6%
  • Public and other 96.4%

Who owns Virax Biolabs Group stock?

Institutional investors own about 2.0% of Virax Biolabs Group's shares, spread across 2 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.58% of VRAX.

The largest institutional holders are Jane Street Group, LLC (3.31%) and UBS Group AG (0.00%).

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of VRAX

Virax Biolabs Group top institutional holders
InstitutionShares% HeldChange
Jane Street Group, LLC26.39K3.31%+100.0%
UBS Group AG40.00%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of VRAX

Virax Biolabs Group top fund holders
FundShares% Held
Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St10.00%

Frequently asked questions

Who is the largest shareholder of Virax Biolabs Group?

Jane Street Group, LLC is the largest institutional shareholder of VRAX, owning 3.31% of shares outstanding (26.39K shares) as of its latest 13F filing.

What percentage of Virax Biolabs Group is owned by institutions?

Institutions own about 2.0% of VRAX shares and 2.0% of the public float.

How much of Virax Biolabs Group do insiders own?

Insiders, such as officers and directors, own about 1.58% of VRAX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related